(Q45749670)

English

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

scientific article published in May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

Robinson HL

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Montefiori DC

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Johnson RP

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Manson KH

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Kalish ML

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Lifson JD

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Rizvi TA

7

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Lu S

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Hu SL

9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Mazzara GP

10

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Panicali DL

11

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Herndon JG

12

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Glickman R

13

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Candido MA

14

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Lydy SL

15

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Wyand MS

16

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

McClure HM

17

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Nature Medicine

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

526-534

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

https://scigraph.springernature.com/pub.10.1038/8406

0 references

Why do we not have an HIV vaccine and how can we make one? .

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological and virologic characteristics of primary HIV infection

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuated HIV vaccine: caveats.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

An evaluation of partner notification for HIV infection in genitourinary medicine clinics in England.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-Neutralizing Antibodies in Rabbits Immunized with HIV-1 gp160 Purified from Simian Cells Infected with a Recombinant Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward an HIV type 1 vaccine that generates potent, broadly cross-reactive neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of cytokines in determining T-lymphocyte function

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Live attenuated AIDS vaccines: hazards and hopes

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Dimensions Publication ID

0 references

release_mss2xnl7ubbeznjxpq2daj5aha

1 reference

https://api.fatcat.wiki/v0/release/mss2xnl7ubbeznjxpq2daj5aha

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10229229

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45749670&oldid=2080944083"